InvestorsHub Logo
Followers 40
Posts 1805
Boards Moderated 0
Alias Born 07/26/2019

Re: rafunrafun post# 334386

Sunday, 04/11/2021 11:04:28 AM

Sunday, April 11, 2021 11:04:28 AM

Post# of 430289
Lets follow that reasoning Raf:
Mythical conversation; Act 1 scene 1
Judge Du: "Is this true, guys"
Amrn: "Er..Er..YES"
Judge Du:" Why didn't you point it out during trial?"
Amrn: "We kinda did..look at what Toth said about the Mori statistics. We thought it wasn't as important as showing you that EPA effects were uniquely distinguished in the TG>500mg/dl population. But you didn't seem to care much about that after hearing about that one theoretical maybe mythical patient in Hayashi"
Judge Du:" So what about Kurabayashi?"
Amrn: "Once again we thought you would be interested in the LDL part and that the patients had essentially the same TG levels as a normal population"
Judge Du: "But why did you ignore the ApoB. After all it was the basis of your patents being granted?"
Amrn: "Well, we thought Kurabayshi didn't show anything of relevance in the prior art to disproving our MARINE findings of EPA on ApoB. After all. wasn't it a negative study according to the authors? That is IF you assume the authors statistics were done right?"
Judge DU: "I see"
QED Quad erat demonstrandum
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News